Clinical Trial Applications (CTAs) - requirements

The following section provides the requirements for a CTA involving the use of pharmaceutical, biological, and radiopharmaceutical drugs. The requirements are the same for these drug products with a few exceptions.

Data and Resources

Additional Info

Field Value
Last Updated April 17, 2026, 17:59 (UTC)
Created April 17, 2026, 17:59 (UTC)
criticality_level []
geographic_scope []
open_canada_collection publication
open_canada_date_published 2017-05-18 00:00:00
open_canada_keywords {"fr": ["demandes d'essais cliniques", "CTA", "CTA impliquant des produits pharmaceutiques", "CTA impliquant des produits biologiques", "CTA impliquant des médicaments radiopharmaceutiques"], "en": ["clinical trial applications", "CTAs", "CTA involving pharmaceutical", "CTA involving biological", "CTA involving radiopharmaceutical-drugs"]}
open_canada_subject ["health_and_safety"]
sensitivity_level unrestricted
title_fr Réunion de consultation préalable au dépôt d'une Demande d'essais clinique
update_frequency as_needed